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LytM is a Staphylococcus aureus autolysin and a homologue of the S. simulans lysostaphin. Both 
enzymes are members of M23 metallopeptidase family (MEROPS) comprising primarily bacterial 
peptidoglycan hydrolases. LytM occurs naturally in a latent form, but can be activated by cleavage 
of an inhibitory N-terminal proregion. Here, we present a 1.45 Å crystal structure of LytM catalytic 
domain with a transition state analogue, tetraglycine phosphinate, bound in the active site. In the 
electron density, the active site of the peptidase, the phosphinate and the “diglycine” fragment on 
the P1′ side of the transition state analogue are very well defined. The density is much poorer or 
even absent for the P1 side of the ligand. The structure is consistent with the involvement of His260 
and/or His291 in the activation of the water nucleophile and suggests a possible catalytic role for 
Tyr204, which we confirmed by mutagenesis. Possible mechanisms of catalysis and the structural 
basis of substrate specificity are discussed based on the structure analysis.
LytM belongs to M23 family of zinc dependent metallopeptidases (MEROPS1), which comprises M23A 
family proteins, represented by P. aeruginosa LasA, and M23B family proteins, including LytM and lys-
ostaphin. LytM was originally identified in an autolysis defective mutant of S. aureus2, and like the other 
M23B family proteins, has glycylglycine endopeptidase activity. LytM cleaves staphylococcal peptidogly-
can in vitro and acts as an autolysin in vivo2. Other roles for the protein have also been proposed, e.g. 
vancomycine resistance3 or the release of protein A from the cell walls of S. aureus4.
Over the past years, many members of the M23 metallopeptidase family have been identified and 
biochemically characterized. Structures have been determined for some of them, e.g. LytM5,6, LasA7 and 
recently lysostaphin, a prototypic enzyme of the M23B group and the best studied bacteriocin8. LytM is 
a two-domain protein: the N-terminal domain is preceded by a signal peptide, the C-terminal domain 
can be divided into an occluding region and a region of high similarity to the lysostaphin catalytic 
domain (52% amino acid identity over 106 residues). In the full length LytM structure, a Zn2+ cation is 
tetrahedrally coordinated by the side chains of N117, H210, D214 and H293. The N117 residue of the 
occluding region blocks part of the active site cleft and occupies a coordination site for the substrate 
carbonyl oxygen. Therefore, proteolytic processing of LytM is required for its activation at least in vitro. 
This latency mechanism has been termed “asparagine switch”5 by analogy to the cysteine switch regulat-
ing matrix metallopeptidases9.
Several crystal forms of either full length LytM and its analogues or their catalytic domains have 
been described before. However the substrate/inhibitor complex of an enzyme of this class remained 
elusive. Therefore details of the catalytic mechanism and the structural basis of substrate specificity have 
remained unclear. We have addressed these issues by a structural analysis of LytM catalytic domain 
in complex with transition state analogue. The findings may also be helpful for attempts to modify 
the substrate specificity of these biotechnologically and medically relevant enzymes. Many of the M23 
enzymes, in particular lysostaphin, display potent bacteriolytic activity also against antibiotic resistant 
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strains, which find use in experimental treatment of infected patients, elimination of S. aureus in asymp-
tomatic carriers, eradication of biofilms from artificial surfaces or antibacterial catheter coatings, and 
other applications10–14.
Results and Discussion
Co-crystal structure. Crystals of LytM in complex with tetraglycine phosphinate were monoclinic 
(space group P21) and contained four LytM-phosphinate complexes in the asymmetric unit. They dif-
fracted to 1.45 Å on a synchrotron beamline with average B-factor 16.7 Å2 (according to the XDS cal-
culated Wilson plot15). The structure was solved by molecular replacement using the structure of LytM 
(2B0P) and refined to final Rwork and Rfree factors of 14.9% and 18.5%, respectively (Fig. 1A and Suppl. 
Table 1). All four LytM copies in the asymmetric unit were very similar (all atom rmsds of around 
0.6 Å), even though NCS restraints were not used for refinement. The ligand density was very strong 
for the phosphinate phosphorus and oxygen atoms, and also for the “diglycine” on the primed side 
(downstream of the scissile bond/phosphinate, Schechter and Berger nomenclature16). In contrast, the 
density was weak or absent on the non-primed site (upstream of the scissile bond/phosphinate) and this 
part of the ligand was modeled only tentatively (Fig. 1B). Average B was lowest for the protein (13 Å2), 
slightly higher for the primed site and P1 residue of the phosphinate (17 Å2) and highest (40 Å2) for the 
P2 residue of the phosphinate (B-factors were calculated for full occupancy and single conformation of 
the phosphinate and then the alternatives were averaged).
Local phosphinate environment, implications for catalysis. The tetraglycine phosphinate mim-
ics the transition state of pentaglycine crossbridge hydrolysis. We use proR and proS labels for the oxygen 
atoms according to the IUPAC rules applied to the transition state intermediate (and not the phosphi-
nate itself) to make the terminology independent of the analogue used to elucidate mechanism. In this 
convention, the proR and proS oxygen atoms are 1.9 and 3.0 Å away from the Zn2+ cation, respectively 
(Fig. 1C). The observed distances suggest identification of the transition state proR oxygen atom with the 
carbonyl oxygen atom of the substrate and of the proS oxygen atom with the incoming water molecule 
or hydroxide ion. This implies polarization of the scissile amide bond due to the coordination of the 
carbonyl oxygen atom by the Zn2+ ion in the active site, as in almost all detailed proposals for catalysis 
by single cation metallopeptidases17,18. It also implies that the nucleophilic water molecule or hydroxide 
ion has to approach from the si face of the amide bond (Fig.  2). In this scenario, the metal ion is not 
involved in the activation of the nucleophile, as proposed for some but not all metallopeptidases17,18. 
Instead, the structure suggests that the incoming water molecule/hydroxide ion is activated by His260 
and His291, as tentatively already proposed in the case of LytM19, and for the equivalent histidines also 
in the case of the LytM orthologue LasA7. In the experimental structure of the phosphinate complex, 
the oxygen atom that would correspond to the proS oxygen of the transition state is 2.6 and 2.8 Å away 
from the Nε atoms of His260 and His291, respectively (Fig. 1C). Loss of activity when either histidine 
is replaced by alanine in LytM5,19 (or its lysostaphin20, LasA21 and Ale-122 homologues) supports a role 
of the histidines in catalysis.
The co-crystal structure of LytM with the phosphinate does not only clarify the role of residues in 
the active site previously suspected to be involved in catalysis. It also suggests that a residue not pre-
viously implicated in LytM catalysis, Tyr204, may make an important contribution as it was suggested 
for a corresponding residue in LasA7. The hydroxyl group of Tyr204 donates a hydrogen bond to the 
oxygen atom of the phosphinate that corresponds to the proR oxygen atom of the transition state, which 
we have argued is derived from the scissile amide bond. In the absence of an experimental structure of 
Figure 1. The binding mode of the phosphinate. (A) The overall structure of the LytM catalytic domain in 
complex with the transition state analogue. The loops lining the LytM substrate binding cleft are indicated 
in red. (B) The interactions of the transition state analogue with the protein. The map is the composite omit 
map contoured at 2.0 Å rmsd. (C) Detail of the phosphinate binding mode (only the P1 and P1′ residues 
excluding the carbonyl are shown). Note that the proR and proS assignment is according to IUPAC priorities 
for the transition state and not for the phosphinate itself.
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LytM with a substrate, we cannot be sure where the carbonyl would be located in the Michaelis complex, 
but the interpretation of proS and proR oxygens suggests that it would be located between these atoms. 
If this deduction is correct, then the tyrosine is better positioned to interact with the substrate carbonyl 
oxygen atom in the transition state than in the ground state. In other words, Tyr204 would be expected 
to make a significant contribution to catalysis, somewhat akin to the hydrogen bond donors contrib-
uting to the oxyanion binding in serine peptidases, which also stabilize the tetrahedral intermediate 
of the reaction23. Mutational analysis confirmed the significance of Tyr204 for LytM catalysis. We have 
generated a set of Tyr204 mutants (glycine, alanine, serine, phenylalanine, aspartate and asparagine) and 
tested them in binding and lytic activity assays. In all tested mutants the activity of the enzyme was very 
weak or even completely abolished (Fig. 3A) while peptidoglycan binding remained almost unchanged 
(Fig. 3B). Interestingly, a tyrosine is found in spatially equivalent position also in LasA, even though it is 
located elsewhere in the amino acid sequence (Fig. 4). LytM and LasA are representative in this respect. 
In LytM and other closely related enzymes of the M23B subfamily, the tyrosine is always present close 
to the N-terminal end, within loop 1 (for a nomenclature of loops, see Firczuk et al., 20056 and Spencer 
et al., 20107). In LasA and other M23A family enzymes, the structurally equivalent tyrosine is located in 
the C-terminal part of the sequence. Convergent evolution of a tyrosine in proximity to the proR oxygen 
atom of the transition state further supports a functional role of this tyrosine residue.
Specific protein-transition state analogue interactions. The tetraglycine phosphinate makes sur-
prisingly few specific contacts with the LytM protein. Only its well-ordered, prime side participates in 
the interactions (Fig.  1B). The NH group of the P2′ glycine is involved in a water mediated hydrogen 
bond to the carboxamide oxygen atom of Asn303. A hydrogen bond with good geometry is also possible 
from the carboxamide nitrogen of Asn303 to the terminal carboxylate group of the ligand. In a natural 
peptidoglycan substrate, the peptide chain would be extended in this position, depending on the register 
of cleavage in the pentaglycine crossbridge either by another glycine, or by an amide bond to the stem 
peptide. In such an arrangement, the hydrogen bond from the Asn303 side chain to the carbonyl oxygen 
atom could still be formed. The LytM crystal structure also shows that there is space to continue the 
polypeptide chain beyond the carboxylate of the transition state analogue.
Figure 2. Proposed catalytic mechanism of the LytM class of enzymes. The top left and right bottom 
panels are based on the actual crystal structures of LasA (3IT5) and LytM (presented here) except that in 
the complex with the phosphinate His260 is not protonated, and binds the proS oxygen atom instead. The 
other two panels are models and therefore only the most convincing interactions have been shown but it 
is possible that Tyr204, His260 and His291 would contribute to the substrate/product binding as well. The 
contact between the water coordinating Zn2+ ion and the Tyr204 is observed in some structures (3IT5) but 
not in others (4QPB), and must be weak so that the substrate can displace the water molecule. The LytM 
numbering has been used in all panels.
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The P1′ glycine of the phosphinate is not involved in any direct hydrogen bonding contacts with 
the protein. Its carbonyl oxygen atom is in water mediated contact with side chain of Asn286 and main 
chain of Tyr239. In the experimentally studied phosphinate analogue of the transition state, a methylene 
group replaces the NH group of the transition state. We cannot exclude that this exchange, which alters 
hydrogen bonding properties and geometry might let us miss interactions that could occur in the actual 
transition state.
In general, the scarcity of favorable interactions between the tetraglycine phosphinate and LytM is 
not unexpected. The lack of side chains in the substrate limits the opportunities for specific interac-
tions. The limited number of backbone contacts lets one wonder whether “backwards” bound substrates 
might also be cleaved. We cannot formally exclude this possibility, but consider it unlikely because the 
phosphinate transition state analogue binds in the same orientation in all four independent instances 
in the asymmetric unit of the crystal. Moreover, “backwards” bound peptides, typically derived from 
proregions of zymogens, tend to act as peptidase inhibitors and not substrates, at least in the case of 
cysteine peptidases24,25.
Structural constraints on the amino acid sequence. As the phosphinate is likely to approximate 
the transition state of the reaction, it can be used to derive structural constraints for the amino acid 
sequence of substrate peptides. On the non-primed side of the phosphinate, the electron density is too 
ambiguous for such analysis (Fig. 1B). On the primed side, the computational replacement of P1′ pro-
pionyl residue is possible (Suppl. Fig. 1). Tyr204 and His210 are both sufficiently far away to avoid 
clashes. Near the computationally introduced Cβ atom on this residue, there are two clearly defined 
water molecules in the experimental structure (at distances of 2.5 Å and 3.1 Å, respectively). Thus, there 
is substantial space for bulkier side chains, which could displace the water molecules (an entropically 
Figure 3. Mutant analysis. (A) Activity assay. The activities of Tyr204 mutants were tested in lytic assay 
and compared to the activity of the wild type enzyme. S. aureus cells collected at exponential phase were 
suspended in lysis buffer (50 mM glycine, pH 8.0) to an apparent OD600 ~ 1.0, treated with LytM and its 
mutants (at 100 nM final concentration) and incubated at room temperature for 60 min. The final readout 
of OD was done in triplicates and the experiment was repeated three times. (B) Binding assay. Samples of 
purified proteins (20 μ g) mixed with purified S. aureus peptidoglycans suspended in 50 mM glycine buffer 
(pH 8.0) were incubated for 15 min on ice. Insoluble peptidoglycans with bound proteins and supernatant 
were separated by centrifugation. Control proteins (load) and supernatant with unbound proteins were 
separated by SDS-PAGE and stained with Coomassie. Fractions of proteins bound to peptidoglycans 
generated a smear on SDS-PAGE and are not shown in the figure.
Figure 4. Active site of LytM and related proteins: LytM (current structure), Lss—lysostaphin from 
Staphylococcus simulans (4QPB), LasA from Pseudomonas aeruginosa (3IT5). Orange spheres—zinc ions, 
red spheres—water molecules coordinating zinc ions.
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favored process). We conclude that a stringent selection of the P1′ residue is not expected based on the 
structure, at least not by steric exclusion. Conclusions are different for the next residue downstream. 
When a Cβ -amino acid is computationally grafted onto this residue, it comes too close (2.7 Å) to the 
main chain of Gly241. A comparison with previous LytM structures shows moderate flexibility of the 
loop containing Gly241, which is not sufficient to relieve the clash. Hence, we expect that steric exclusion 
contributes to selectivity for the P2′ glycine residue (Suppl. Fig. 1).
Comparison with previously observed binding modes of glycine rich loop. LytM happens 
to contain a surface exposed loop distant from the active site with 3 consecutive glycine residues 
(Gly206-Gly208). In two previous crystal forms, this loop comes close to the active site of another LytM 
molecule, so that it might mimic the binding of a substrate6. However, it was already noticed in the pre-
vious work that the glycine-rich loop was running through the active site region in opposite directions in 
different crystal forms (Fig. 5). Moreover, the resolution was sufficient to conclude that the loop was not 
cleaved in the “incidental” crystallographic contacts, and therefore could not mimic the binding mode 
of a substrate accurately6. We have now revisited the previously observed binding modes in the light of 
the experimental density for the phosphinate. The glycine rich loop of a neighboring molecule in the 
P41 crystal form (PDB: 2B13) runs indeed through the region of the active site cleft also occupied by the 
well-defined part of the phosphinate, but the direction of the polypeptide chain is reversed (Fig. 5C). The 
loop from the neighboring molecule in the P3221 crystal form (PDB: 2B44) runs in the correct direction, 
but is very significantly displaced relative to the phosphinate (Fig. 5D). We conclude from this analysis 
that the crystallographic packing effects that were noticed earlier did correctly identify the active site 
cleft, but did not accurately mimic the substrate binding mode.
Comparison with binding mode of the inhibitory N-terminal proregion. LytM is naturally 
made as a latent enzyme with an inhibitory region at its N-terminus, which can be cleaved off even 
by physiologically unrelated peptidases5. Although such LytM activation in physiological circumstances 
has never been shown, this region nevertheless behaves biochemically much like a proregion and will 
be called so in the following. In the previously determined structure of full length LytM5 the proregion 
runs through the active site cleft, but is not cleaved (Fig. 5B). This can be attributed to a relatively large 
distance of the peptide backbone from the active site Zn2+ ion. Additionally the Zn2+ ion is trapped in a 
tetrahedral coordination arrangement with the asparagine carboxamide oxygen atom as the fourth ligand 
in addition to the three usual ones (His210, Asp214, His293). The current structure makes it possible to 
relate the proregion and substrate (analogue) binding modes. We found a surprising similarity between 
the P1′ side of the phosphinate and the 117-NND—119 fragment of the proregion (Fig.  6). Both run 
in the same direction with the distance between corresponding Cα -atoms below 2.0 Å. The agreement 
does not hold for the phosphinate group (corresponding to the scissile bond). Whereas the phosphinate 
runs straight through the active site, the proregion kinks sharply. This kink provides sufficient distance 
for the “asparagine switch” Asn117 residue to contact the metal via the carbonyl oxygen atom of the side 
and not main chain. We conclude from this analysis that the proregion of LytM mimics a substrate in 
the primed, but not in the non-primed region of the substrate binding cleft.
Comparison of the substrate binding modes in the LytM/lysostaphin and LasA families. LytM 
belongs to the same group of evolutionarily related peptidases as lysostaphin and LasA (MEROPS family 
M23). The binding mode of peptides to LasA has been investigated in detail by computational studies. 
The substrate binding cleft of the enzyme is lined by four loops, which are conserved also in lysostaphin 
and LytM. The catalytic Zn2+ ion is located at the bottom of this cleft. Based on computational results 
Figure 5. Peptides and analogues in the substrate binding groove of LytM. (A) LytM catalytic domain 
with the phosphinate transition state analogue; (B) full length LytM with active site blocked by peptide from 
occluding region (PDB 1QWY); (C,D) catalytic domain of LytM with glycine rich loop from neighboring 
molecule wedged into the active site cleft (P41 (2B13) and P3221 (2B44) crystal forms). Arrows mark the 
direction of the main chain in the transition state analogue and protein fragments occupying in the cleft.
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Spencer and colleagues7 have concluded that LasA binds its substrates in an orientation that puts the 
N-terminus closer to loops 1 and 3 and the C-terminus closer to loops 2 and 4.
The location of the binding cleft and substrate orientation predicted for LasA agree with the phosph-
inate binding mode presented here, supporting the generality of the broader conclusions from this work. 
However, the details of substrate binding are distinctly different: while the tetraglycine phosphinate in 
LytM adopts an extended, β -strand like structure, the trace of the modeled LasA substrate peptide chain 
is more irregular, and in some cases, amide bonds in adjacent residues are oriented perpendicular to each 
other7. When the LasA substrate is modelled according to the binding mode of the phosphinate to LytM, 
the LasA specificity (in particular the preference for a P1′ phenylalanine residue) remains unexplained. 
Therefore, we conclude that the detailed differences in the binding modes of LytM and LasA are likely 
genuine and not modeling/experiment artifacts.
Conclusions
The structure of LytM with a tetraglycine phosphinate transition state analogue reveals details of the 
catalytic mechanism. It supports the role of His260 and His291 in activation of the nucleophilic water 
molecule or hydroxide ion, and suggests a previously unrecognized catalytic role for Tyr204. The tyrosine 
may help by hydrogen bonding to stabilize the oxyanion intermediate of the reaction (akin to the role of 
the oxyanion hole in serine peptidases). A catalytic function of Tyr204, which is structurally conserved 
in the entire M23 family, is also supported by site-directed mutagenesis experiments. The LytM phosph-
inate co-crystal structure also helps to identify the structural determinants of substrate recognition and 
binding.
Methods
Protein purification. The catalytic domain of LytM (residues 185–316) was cloned into expression 
plasmid (pET15b) under the control of the T7 promoter and lac repressor as described previously6. For 
protein expression, transformed BL21(DE3) E. coli cells were grown in autoinductive medium (Auto 
Induction Medium LB Broth Base including trace elements, Formedium, UK) for 24 hours at 30 °C. Cells 
were harvested and resuspended in buffer A (20 mM Tris-HCl, pH 7.5, 50 mM NaCl). After cell disrup-
tion by Constant Cell Disruption System (Constant System Ltd., UK) and clarification of the lysate, the 
supernatant was applied to a SP Sepharose FF column (GE Healthcare, Sweden) equilibrated in buffer A. 
The protein recovered in the flow through was 90% pure. After concentration, the protein was subjected 
to gel filtration step on Superdex 75 column (GE Healthcare, Sweden) in buffer A.
Crystallization and structure determination. Several different crystal forms of LytM catalytic 
domain have been reported before6. In this work, we found an additional crystallization condition, which 
led to strongly diffracting crystals in space group P21. Catalytic domain of LytM (12 mg ml−1) was mixed 
in 1:1 ratio with the reservoir buffer containing 50 mM HEPES-CsOH pH 7.5, 200 mM calcium chloride 
and 25% polyethylene glycol 4000. Crystallization experiments were carried out by the vapor diffusion 
method in sitting drops at 17 °C. Crystals grew during a month of equilibration against the reservoir 
buffer.
The datasets were measured at the 14.1 and 14.2 beamlines of BESSY synchrotron (Berlin, Germany). 
The best crystals diffracted to about 1.2 Å. Data was processed with the help of XDS software26. The 
structure was readily interpreted by molecular replacement using previously published LytM catalytic 
domain structure6 with the help of MolRep27 and ARP/wARP28 programs. The crystals contained four 
molecules in the asymmetric unit. In each of the molecules the active site was solvent accessible and 
allowed for the ligand binding.
Unfortunately, attempts to co-crystallize LytM catalytic domain with substrate analogues, includ-
ing tetraglycine, glycine hydroxamate and short peptides, such as GGSGG or GGA, all led to electron 
Figure 6. Transition state analogue and inhibitory proregion in the LytM substrate binding groove. (A) 
Tetraglycine phosphinate and (B) proregion (PDB 1QWY).
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densities in which the ligand was either altogether absent or very poorly defined. Findings were very 
similar when the analogues were not added to the crystallization mix, but instead soaked into crystals. 
We reasoned that the failure to obtain complexes might be related to the very poor activity of LytM in 
“high salt” buffers. Therefore, we soaked crystals of the newly identified crystal form in low salt (low 
conductivity) conditions where 50–60 mM substrate analogue solution in 30% polyethylene glycol 4000 
(0.5 μ l) was added to crystallization drop (0.2 μ l). Crystals were then harvested and cryoprotected in 
the same conditions at various time points ranging from minutes to 4 weeks of incubation. Most of the 
tested crystals had an additional density in the active center, but only the incubation with phosphinic 
derivative of tetraglycine (H-Gly-Glyψ [P(O)(OH)CH2]-Gly-Gly-OH) led to the diffraction data quality 
that allowed unquestionable identification of the ligand. The structure was refined with REFMAC29 and 
PHENIX30 and manually improved in COOT31. Data and refinement statistics are summarized in Suppl. 
Table 1. The atomic coordinates of the final model and the corresponding structure factors have been 
deposited in the Protein Data Bank (accession code 4ZYB).
Mutagenesis. LytM catalytic domain mutants: Y204A, Y204D, Y204F, Y204G, Y204N and Y204S 
were generated by PCR-based site-directed mutagenesis according to the manufacturer protocol with 
Phusion high-fidelity DNA polymerase (Thermo Scientific, USA) using pET15b-LytMCD plasmid as a 
PCR template. In order to confirm that only the intended mutations were introduced, all of the DNA 
constructs of the mutants were sequenced. The wild-type protein and mutants were overexpressed with 
an N-terminal histidine tag as described above. The collected cells were harvested and the lysate was used 
for protein purification. The first purification step was performed on a 5 ml precharged Ni SepharoseTM 
High Performance HisTrapTM HP column (GE Healthcare, Sweden). The imidazole gradient was run 
from 50 mM to 1 M in buffer B (20 mM Tris-HCl pH 7.0, 200 mM NaCl). Histidine-tagged LytM mutants 
eluted at 300–400 mM imidazole. After concentration, the proteins were subjected to gel filtration step 
on Superdex 75 column (GE Healthcare, Sweden) in buffer B supplemented with 10% glycerol as a final 
purification step.
Cell lysis assay. S. aureus 8325–4 strain cells collected at the exponential growth phase were washed 
and suspended in buffer C (50 mM glycine, pH 8.0) to an apparent OD595 of 0.8–1.0. Enzymes were 
added to the final concentration of 100 nM and 200 μ l of reaction transferred onto the microtiter plate. 
Plates were incubated at room temperature and OD of the suspension was checked at the wavelength of 
595 nm every 10 min for 1 hour with 5 sec shaking. Lytic activity was calculated as a percentage of initial 
OD595. Each experiment was repeated three times in triplicates.
Peptidoglycan binding assay. The binding of proteins to peptidoglycans (PG) purified according to 
previously described protocol5 was observed following incubation of 10 μ g protein with peptidoglycan 
at OD600 = 20 in 50 μ l of buffer C at 4 °C for 15 minutes. Mixtures were separated by centrifugation into 
bound (pellet) and unbound (supernatant) fractions which were then analyzed on 15% SDS-PAGE gels.
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